KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Discontinued OperationsCash from Discontinued OperationsCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Travere Therapeutics (TVTX) Change in Accured Expenses (2016 - 2025)

Travere Therapeutics' Change in Accured Expenses history spans 15 years, with the latest figure at -$3.4 million for Q4 2025.

  • For Q4 2025, Change in Accured Expenses fell 113.91% year-over-year to -$3.4 million; the TTM value through Dec 2025 reached -$9.7 million, down 271.8%, while the annual FY2025 figure was -$9.7 million, 271.8% down from the prior year.
  • Change in Accured Expenses reached -$3.4 million in Q4 2025 per TVTX's latest filing, down from -$1.1 million in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of $26.0 million in Q4 2023 to a low of -$24.8 million in Q1 2024.
  • Average Change in Accured Expenses over 5 years is $2.2 million, with a median of $16000.0 recorded in 2021.
  • Peak YoY movement for Change in Accured Expenses: soared 1638.66% in 2023, then crashed 6977.21% in 2024.
  • A 5-year view of Change in Accured Expenses shows it stood at $5.4 million in 2021, then rose by 13.31% to $6.2 million in 2022, then surged by 320.87% to $26.0 million in 2023, then decreased by 6.78% to $24.2 million in 2024, then plummeted by 113.91% to -$3.4 million in 2025.
  • Per Business Quant, the three most recent readings for TVTX's Change in Accured Expenses are -$3.4 million (Q4 2025), -$1.1 million (Q3 2025), and $3.1 million (Q2 2025).